BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bristol-Myers Squibb Company (BMY) Abandons Three R&D Areas, Slashes 70+ Jobs


11/8/2013 7:33:12 AM

Bristol-Myers is cutting jobs but others are hiring right now! Check it out! (Isn't it tempting?)

Bristol-Myers Squibb has laid off as many as 20 people in its clinical development/operations group at ZymoGenetics in Seattle as part of a companywide R&D restructuring, Xconomy has learned. New York-based Bristol-Myers acquired ZymoGenetics for about $885 million in October 2010, and pledged a few months later to retain the remaining 275 employees at the Seattle biotech company. Bristol-Myers allowed the local operation keep its landmark headquarters, the former City Light Steam Plant, and its ZymoGenetics identity and brand logo on the sign above the door on Eastlake Avenue East.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)


Read at Xconomy
Read at BusinessWeek
Read at Pharma Times [Free Reg Req'd]
Read at Pharmalot
Read at Reuters

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES